ANTIKÖRPER GEGEN INTERLEUKIN-1-BETA

Patent europeic · EP1851245 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1851245
Numer da la dumonda
EP06718993
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-01-2006
Publitgà
07-11-2007
Concedì
10-10-2012
Stritgà
31-01-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 16/24 (2006.01)
Prioritad
US 647643 P 26.01.2005
US 753800 P 22.12.2005
Dumonda PCT
PCT/US2006/002011 19.01.2006
Publicaziun PCT
WO2006/081139 03.08.2006
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-08-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.08.2015

  2. 01-11-2012

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 01.11.2012

  3. 10-10-2012

    Concedì

    Published in Swissreg on 10.10.2012

Partidas

Possessur

Amgen Fremont Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

GREEN, Larry

San Francisco, California 94114, US

FAGGIONI, Raffaella

Pleasanton, California 94566, US

FOORD, Orit

Foster City, California 94404, US

KLAKAMP, Scott, L.

Fremont, California 94536, US

SENALDI, Giorgio

Dublin, California 94568, US

SCHNEIDER, Amy, K.

Dublin, California 94568, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.